Solid Biosciences Inc. (SLDB) quarterly cash flow statement — complete operating, investing & financing history
Solid Biosciences Inc. (SLDB) cash flow statement — 11-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -52.59M | -47.23M | -53.55M | -33.47M | -37.41M | -31.85M | -29.64M | -23.71M | -21.47M | -25.19M | -20.82M | -17.9M | -27.46M | -28M | -34.48M | -20.43M | -15.88M | -27.19M | -20.87M | -18.42M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -257.38% | -1412.47% | -661.83% | -520.89% |
| Operating CF Growth % | -40.56% | -48.29% | -80.65% | -41.18% | -74.28% | -26.43% | -42.37% | -32.47% | 21.84% | 10.01% | 39.61% | 12.39% | -72.98% | -2.96% | -65.18% | -10.88% | 7.15% | -27.26% | -1697.09% | -18.38% |
| Net Income | -54.8M | -56.74M | -49.79M | -45.78M | -39.48M | -39.28M | -42.6M | -32.73M | -25.07M | -24.3M | -20.34M | -20.98M | -24.63M | -30.07M | -15.15M | -20.41M | -25.09M | -25.33M | -18.61M | -17.98M |
| Depreciation & Amortization | 391K | -619K | -28K | 376K | -488K | 407K | 488K | 405K | 1.24M | 327K | 587K | 588K | 703K | 1.08M | 539K | 438K | 722K | 709K | 760K | 751K |
| Stock-Based Compensation | 5.62M | 5.15M | 6.5M | 3.93M | 3.15M | 3.34M | 3.82M | 3M | 2.09M | 1.61M | 1.94M | 1.63M | 1.94M | 2.12M | 1.59M | 1.52M | 1.81M | 2.61M | 3.42M | 3.42M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.98M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.04M | 2.67M | 3.01M | 827K | 1.95M | 1.89M | 6.51M | 2.78M | 200K | -634K | 1.83M | -350K | 1.19M | -215K | -18.51M | -17K | -94K | 371K | 584K | 534K |
| Working Capital Changes | -2.76M | 2.31M | -13.25M | 7.17M | -2.54M | 1.79M | 2.13M | 2.84M | 78K | -2.19M | -1.86M | 1.22M | -6.67M | -905K | -2.94M | -1.96M | 6.77M | -5.55M | -7.02M | -5.14M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14K | 96K | 484K | -308K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.18M | 2.32M | -5.26M | 3.7M | 6K | 461K | 815K | 918K | 1.07M | -596K | 134K | -929K | -2.71M | 2.75M | -5.91M | 287K | 302K | 71K | 570K | 957K |
| Cash from Investing | -133.59M | 44.76M | 47.01M | -45.27M | -32.73M | -27.46M | 38.57M | -10.99M | -5.18M | -38.49M | 45.3M | -24.64M | -48.23M | 37.26M | 66.1M | 14.91M | -59.59M | 37.74M | 30.18M | -72.51M |
| Capital Expenditures | -150K | -165K | -565K | -85K | -377K | -126K | -204K | -15K | -286K | -149K | -90K | -383K | -536K | -506K | -856K | -839K | -1.14M | -184K | -660K | -237K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 18.41% | 9.56% | 20.93% | 6.7% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -45.39M | 0 | 0 | 0 | 0 | 0 | 58.46M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 85K | 0 | 0 | 0 | 0 | 5K | 45.39M | 0 | 0 | 0 | 31.52M | 600K | -58.46M | 0 | 0 | 0 |
| Cash from Financing | 48.47M | 239.03M | 5.14M | 1.18M | -1.6M | 189.73M | 6.94M | 3.26M | 5M | 107.24M | 505K | 0 | 2.62M | 0 | 74.74M | -1K | 73K | 22K | 66K | 3K |
| Debt Issued (Net) | 0 | 0 | -203K | -243K | -142K | -135K | -128K | -120K | -225K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 49.25M | 239.03M | 5.12M | 1.47M | -1.66M | 189.86M | 6.86M | -2.01M | 5.37M | 112.07M | 435K | 0 | 2.54M | 0 | 72.55M | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -12.89M | 0 | 0 | 0 | -20K | 0 | -5.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -781K | 0 | 229K | -50K | 196K | 0 | 211K | 5.39M | -141K | -4.83M | 70K | 0 | 78K | 0 | 2.19M | -1K | 73K | 22K | 66K | 3K |
| Net Change in Cash | -137.71M | 236.56M | -1.4M | -77.57M | -71.75M | 130.41M | 15.86M | -31.44M | -21.72M | 43.56M | 24.98M | -42.53M | -73.08M | 9.27M | 106.36M | -5.52M | -75.4M | 10.57M | 9.37M | -90.93M |
| Free Cash Flow | -52.74M | -47.4M | -54.12M | -33.56M | -37.79M | -31.98M | -29.85M | -23.72M | -21.75M | -25.34M | -20.91M | -18.28M | -28M | -28.5M | -35.34M | -21.27M | -17.01M | -27.37M | -21.53M | -18.66M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -275.8% | -1422.03% | -682.75% | -527.59% |
| FCF Growth % | -39.56% | -48.22% | -81.31% | -41.45% | -73.72% | -26.18% | -42.73% | -29.78% | 22.31% | 11.09% | 40.82% | 14.05% | -64.58% | -4.12% | -64.09% | -13.97% | 2.49% | -27.91% | -1826.86% | -19.29% |
| FCF per Share | -0.37 | -0.43 | -0.57 | -0.36 | -0.40 | -0.48 | -0.56 | -0.57 | -0.53 | -0.66 | -0.72 | -0.91 | -1.42 | -1.46 | -4.40 | -2.82 | -2.26 | -3.65 | -2.88 | -2.49 |
| FCF Conversion (FCF/Net Income) | 0.96x | 0.83x | 1.08x | 0.73x | 0.95x | 0.81x | 0.70x | 0.72x | 0.86x | 1.04x | 1.02x | 0.85x | 1.12x | 0.93x | 2.28x | 1.00x | 0.63x | 1.07x | 1.12x | 1.02x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 68K | 0 | 82K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |